Background Amiodarone is an antiarrhythmic drug that has been recognized to induce
hepatotoxicity. We report a case of acute-on-chronic liver failure (ACLF) in a patient who was …

The anti-arrhythmic agent amiodarone (AD) is associated with numerous adverse effects,
but serious liver disease is rare. The improved safety of administration of daily low doses of …

We present the first description of amiodarone toxicity in the liver without phospholipidosis or
steatosis. In doing so, we will review the various effects of amiodarone toxicity in various …

Amiodarone is a widely used and effective long-term antiarrhythmic drug but with known
adverse effects. Prolonged oral administration of this drug has been implicated in numerous …

Background Amiodarone is a class III anti-arrhythmic drug that is commonly used for
management of tachyarrhythmias. Amiodarone hepatotoxicity resulting in cirrhosis is an …

We present a case report of an 80-year-old woman with volume overload thought initially to
be secondary to heart failure, but determined to be amiodarone-induced acute and chronic …

Abstract Background and Aims: Hepatotoxic complications of long-term oral amiodarone
therapy have been well described; however, liver injury secondary to parenteral infusion of …

Introduction Amiodarone can induced hepatic dysfunction. Observations We describe two
patients who developed hepatotoxicity presenting suggestive histological features. The …

A72-year-old Korean male was admitted because of sudden onset of abdominal distension.
He had been treated with amiodarone 200 mg, felodipine 5 mg, hydrochlorothiazide 25 mg …

Nonalcoholic steatosis/steatohepatitis is the most common cause for abnormal liver
chemistries. Apart from metabolic syndrome, drugs may also lead to development of …